SGLT-2 Inhibitors in Heart Failure: Implications for the Kidneys.

about

Why Diuretics Fail Failing Hearts.

P2860

Q52758605-37CD467D-4171-4706-8F2F-1860535D0F76

P2860

SGLT-2 Inhibitors in Heart Failure: Implications for the Kidneys.

Item

http://www.wikidata.org/entity/Q39408236

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

SGLT-2 Inhibitors in Heart Failure: Implications for the Kidneys.

@en

SGLT-2 Inhibitors in Heart Failure: Implications for the Kidneys.

@nl

type

Item

label

SGLT-2 Inhibitors in Heart Failure: Implications for the Kidneys.

@en

SGLT-2 Inhibitors in Heart Failure: Implications for the Kidneys.

@nl

prefLabel

SGLT-2 Inhibitors in Heart Failure: Implications for the Kidneys.

@en

SGLT-2 Inhibitors in Heart Failure: Implications for the Kidneys.

@nl

P1476

SGLT-2 Inhibitors in Heart Failure: Implications for the Kidneys.

@en

P2093

Frederik H Verbrugge

http://www.w3.org/2001/XMLSchema#string

Pieter Martens

http://www.w3.org/2001/XMLSchema#string

Wilfried Mullens

http://www.w3.org/2001/XMLSchema#string

P2860

The kidney in congestive heart failure: 'are natriuresis, sodium, and diuretics really the good, the bad and the ugly?'

Management of the cardiorenal syndrome in decompensated heart failure

Molecular analysis of the SGLT2 gene in patients with renal glucosuria

Autosomal recessive renal glucosuria attributable to a mutation in the sodium glucose cotransporter (SGLT2)

Twenty-one additional cases of familial renal glucosuria: absence of genetic heterogeneity, high prevalence of private mutations and further evidence of volume depletion

Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis

Impaired natriuretic and renal endocrine response to acute volume expansion in pre-clinical systolic and diastolic dysfunction.

Hormones and hemodynamics in heart failure.

Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor.

Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival.

P2888

s11897-017-0345-9

P304

331-337

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11897-017-0345-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28667491

http://www.w3.org/2001/XMLSchema#string

P921

heart failure

SGLT-2 Inhibitors in Heart Failure: Implications for the Kidneys.

about

P2860

P2860

SGLT-2 Inhibitors in Heart Failure: Implications for the Kidneys.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921